A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/495 (2006.01) A61K 9/20 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2678319
Disclosed is the treatment of patients suffering from coronary microvascular disease comprising with ranolazine. In one embodiment, ranolazine is administered as an oral dose.
L'invention concerne le traitement par la ranolazine de patients souffrant de maladie microvasculaire coronaire. Dans un mode de réalisation, la ranolazine est administrée sous forme de dose orale.
Belardinelli Luiz
Blackburn Brent
Wolff Andrew
Cv Therapeutics Inc.
Gilead Palo Alto Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Use of ranolazine for the treatment of coronary... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ranolazine for the treatment of coronary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ranolazine for the treatment of coronary... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1593660